Pharvaris (PHVS) Cash & Current Investments (2019 - 2026)

Pharvaris (PHVS) reported Cash & Current Investments of $289.1 million for Q1 2026, down 2.09% on a YoY basis from $295.3 million in Q1 2025, and down 14.84% quarter-over-quarter from $339.5 million in Q4 2025.

Pharvaris (PHVS) Cash & Current Investments (2019 - 2026) Analysis & Trends

Pharvaris has reported Cash & Current Investments for 8 years, with the latest figure at $289.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments fell 2.09% year-over-year to $289.1 million; the trailing twelve-month figure through Mar 2026 stood at $289.1 million (down 2.09% YoY), and the FY2025 full-year result was $329.5 million, up 8.46% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $289.1 million, down from $339.5 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $429.7 million in Q3 2024, with the low at $176.23 in Q2 2023.
  • Historically, Cash & Current Investments has averaged $249.3 million across 5 years, with a median of $235.0 million in 2022.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments sank 100.0% — and 2025, when it soared 53619744.65%.
  • Pharvaris' Cash & Current Investments stood at $165.1 million in 2022, then surged by 154.94% to $420.9 million in 2023, then declined by 28.73% to $300.0 million in 2024, then rose by 13.18% to $339.5 million in 2025, then fell by 14.84% to $289.1 million in 2026.
  • The last three Cash & Current Investments figures came in at $289.1 million (Q1 2026), $339.5 million (Q4 2025), and $328.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 32.30 Mn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 2.13 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 286.70 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 2.77 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 18.44 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 7.25 Bn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Pharvaris 28.66 Bn 28.37 Bn - 289.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 289.13 Mn
Dec 31, 2025 339.53 Mn
Sep 30, 2025 328.19 Mn
Jun 30, 2025 225.91 Mn
Mar 31, 2025 295.29 Mn
Dec 31, 2024 299.98 Mn
Sep 30, 2024 429.66 Mn
Jun 30, 2024 421.31
Mar 31, 2024 425.02 Mn
Dec 31, 2023 420.94 Mn
Sep 30, 2023 176.17 Mn
Jun 30, 2023 176.23
Mar 31, 2023 173.71 Mn
Dec 31, 2022 165.11 Mn
Sep 30, 2022 211.09 Mn
Jun 30, 2022 223.39 Mn
Mar 31, 2022 234.96 Mn
Dec 31, 2021 239.49 Mn
Sep 30, 2021 116.31 Mn
Jun 30, 2021 118.78 Mn